<--- Back to Details
First PageDocument Content
Food and Drug Administration / Drug discovery / Epidemiology / Pharmaceuticals policy / Orphan drug / Orphan Drug Act / Pharmaceutical industry / Rare disease / Clinical trial / Pharmaceutical sciences / Health / Pharmacology
Food and Drug Administration
Drug discovery
Epidemiology
Pharmaceuticals policy
Orphan drug
Orphan Drug Act
Pharmaceutical industry
Rare disease
Clinical trial
Pharmaceutical sciences
Health
Pharmacology

Office of Orphan Products Development

Add to Reading List

Source URL: www.fda.gov

Download Document from Source Website

File Size: 67,52 KB

Share Document on Facebook

Similar Documents

House of Commons Health Committee The Influence of the Pharmaceutical Industry

DocID: 1v3YA - View Document

Speakers Confirmed BD Biosciences Industry Days A roadshow of talks specifically tailored to those working in the biotechnology, clinical research and pharmaceutical industry. Join leaders in the field and BD experts for

DocID: 1uWLK - View Document

NEWS RELEASE Copley Scientific celebrates seven decades of responsive service to the pharmaceutical industry 17th May 2016: Nottingham, UK: Copley Scientific, a family-owned company that began supplying glassware to the

DocID: 1utWK - View Document

2nd APV Conference on “Highly Potent Drug Products in the Pharmaceutical Industry” 26 to 27 September 2018 Mannheim, Germany

DocID: 1utU5 - View Document

Index of abbreviations AAMC – Australian Army Medical Corps AB – Artium Baccalaureus, Bachelor of Arts Aberd – Aberdeen ABPI – Association of the British Pharmaceutical Industry AC – Companion, Order of Austral

DocID: 1ushC - View Document